Abstract
INTRODUCTION
The aim of this report is to provide a range of information - from detailed
market analyses through industry trends - to quantify, qualify, and compare
prescription products on the market and in development for the treatment of
selected endocrine and metabolic disorders. There is a correlation between
several endocrine and metabolic disorders, and recently there has been
considerable emphasis put on metabolic syndrome, which comprises several
interrelated endocrine and metabolic disorders. The metabolic components of
cardiovascular disease and obesity, for example, are linked in numerous ways
that reflect the impact each has on the other. Reduction in obesity reduces
the incidence of diabetes, and both of these conditions, independently, are
major contributors to cardiovascular disease.
SCOPE OF STUDY
This report contains:
- The major current and emerging markets for prescription drugs for
endocrine and metabolic diseases, including hypertension, infertility, thyroid
diseases, hypercholesterolemia, and obesity
- Historical market data from 2004, 2005, and 2006, in addition to five-year
market forecasts with compounded annual growth rates through 2011
- Discusses applications as well as current and upcoming technology and
trends
- Provides detailed patent analysis and profiles of the major companies in
the biotechnology and pharmaceutical industries that provide products for the
diseases covered in this report.
METHODOLOGY
The base year for this study is 2006. Figures are based on revenue figures at
the manufacturer' s level and are projected at 2006 dollar value - that is,
inflation is not computed into the projection figures.
Data and trends obtained to prepare this study were derived from information
obtained from pharmaceutical product managers, marketing strategists, research
executives, and others at leading biotechnology and pharmaceutical companies
that have products used in the treatment of the diseases covered in this
report, or which have products in development for these markets.
INFORMATION SOURCES
The information and analyses presented in this report are based on an
extensive survey of the pharmaceutical industries, as well as a detailed
examination of published literature and reports obtained from regulatory
authorities, medical research institutions, pharmaceutical trade associations,
and national and world health organizations. Key information from the business
literature was used to obtain expert opinion on commercial potential and
market sizes from industry professionals.
| 
View Cart
